Literature DB >> 18446380

Saccharomyces boulardii prevents oral-poliovirus vaccine-induced IgA nephropathy in mice.

Alper Soylu1, Sema Berktaş, Sülen Sarioğlu, Güven Erbil, Osman Yilmaz, Belde K Demir, Yahya Tufan, Didem Yeşilirmak, Mehmet Türkmen, Salih Kavukçu.   

Abstract

Immunoglobulin A nephropathy (IgAN) is associated with mucosal IgA defect. Probiotics regulate specific and innate immunity. We evaluated the effect of Saccharomyces boulardii on experimental IgAN in mice. Four groups of BALB/c mice (eight for each) were formed. Group 1 was immunized by oral poliovirus vaccine (OPV) at 0, 14, and 28 days. Group 2 was also given S. boulardii in addition to OPV. Group 3 was given only S. boulardii, whereas group 4 received no treatment. At week 6, after urine and serum samples were obtained for urinalysis and serum creatinine and IgA measurements, all animals were sacrificed to get their kidneys for histopathological evaluation. Urinalysis and serum creatinine levels were normal in all groups. Serum IgA level was increased only in group 1. Whereas group 1 had mesangial proliferation, histology was normal in the other groups. Predominant IgA deposition was universal in group 1, whereas it was either not present or minimal in other groups. Three mice in group 1 also had C3 deposition, which was absent in other groups. Electron microscopy revealed mesangial proliferation, matrix expansion, focal glomerular basement membrane thickening and electron-dense deposits in group 1 only, whereas the other groups were normal. In conclusion, enteral S. boulardii prevented OPV-induced IgAN in mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18446380     DOI: 10.1007/s00467-008-0813-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  17 in total

Review 1.  Probiotics: effects on immunity.

Authors:  E Isolauri; Y Sütas; P Kankaanpää; H Arvilommi; S Salminen
Journal:  Am J Clin Nutr       Date:  2001-02       Impact factor: 7.045

Review 2.  Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.

Authors:  Helena Tlaskalová-Hogenová; Renata Stepánková; Tomás Hudcovic; Ludmila Tucková; Bozena Cukrowska; Rája Lodinová-Zádníková; Hana Kozáková; Pavel Rossmann; Jirina Bártová; Dan Sokol; David P Funda; Dana Borovská; Zuzana Reháková; Jirí Sinkora; Jaroslav Hofman; Pavel Drastich; Alena Kokesová
Journal:  Immunol Lett       Date:  2004-05-15       Impact factor: 3.685

3.  The effect of sodium cromoglycate on the induction of experimental IgA nephropathy.

Authors:  S Y Jin; I J Choi
Journal:  Yonsei Med J       Date:  1990-03       Impact factor: 2.759

Review 4.  IgA nephropathy.

Authors:  Jonathan Barratt; John Feehally
Journal:  J Am Soc Nephrol       Date:  2005-06-01       Impact factor: 10.121

5.  Influence of oral intake of Saccharomyces boulardii on Escherichia coli in enteric flora.

Authors:  Ipek Akil; Ozge Yilmaz; Semra Kurutepe; Kenan Degerli; Salih Kavukcu
Journal:  Pediatr Nephrol       Date:  2006-04-20       Impact factor: 3.714

Review 6.  Mechanisms of tubulointerstitial injury in IgA nephropathy.

Authors:  Kar Neng Lai; Loretta Y Y Chan; Joseph C K Leung
Journal:  Kidney Int Suppl       Date:  2005-04       Impact factor: 10.545

7.  Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis.

Authors:  Samir Jawhara; Daniel Poulain
Journal:  Med Mycol       Date:  2007-12       Impact factor: 4.076

8.  Modulation of Clostridium difficile induced mortality as a function of the dose and the viability of the Saccharomyces boulardii used as a preventative agent in gnotobiotic mice.

Authors:  G W Elmer; G Corthier
Journal:  Can J Microbiol       Date:  1991-04       Impact factor: 2.419

Review 9.  Probiotics in gastroenterology: indications and future perspectives.

Authors:  D Goossens; D Jonkers; E Stobberingh; A van den Bogaard; M Russel; R Stockbrügger
Journal:  Scand J Gastroenterol Suppl       Date:  2003

10.  Experimental IgA nephropathy induced by oral immunization.

Authors:  S N Emancipator; G R Gallo; M E Lamm
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Gut Microbes in Immunoglobulin A Nephropathy and Their Potential Therapeutic Applications.

Authors:  Yi Wang; Lingling Tian; Lin Sun; Wenjing Zhou; Wenqiang Zhi; Jianbo Qing; Yasin Abdi Saed; Lina Dong; Xiadong Zhang; Yafeng Li
Journal:  Front Med (Lausanne)       Date:  2022-05-17

2.  Screening of celiac disease in children with Henoch-Schoenlein purpura.

Authors:  Alper Soylu; Yeşim Öztürk; Yavuz Doğan; Derya Özmen; Özlem Yılmaz; Pınar Kuyum; Salih Kavukçu
Journal:  Rheumatol Int       Date:  2016-01-20       Impact factor: 2.631

Review 3.  Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy?

Authors:  Renato C Monteiro; Dina Rafeh; Patrick J Gleeson
Journal:  Microorganisms       Date:  2022-03-22

Review 4.  A New Vision of IgA Nephropathy: The Missing Link.

Authors:  Fabio Sallustio; Claudia Curci; Vincenzo Di Leo; Anna Gallone; Francesco Pesce; Loreto Gesualdo
Journal:  Int J Mol Sci       Date:  2019-12-26       Impact factor: 5.923

Review 5.  Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies.

Authors:  Jia-Wei He; Xu-Jie Zhou; Ji-Cheng Lv; Hong Zhang
Journal:  Theranostics       Date:  2020-09-15       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.